FDA Inspection 1170457 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1071676

The FDA completed an inspection of Octapharma Plasma, Inc. on May 12, 2022 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Charlotte, NC (United States)